Sales and Marketing

Showing 15 posts of 11524 posts found.

European flags

European call for greater HTA co-operation

July 9, 2010 Sales and Marketing hta

The European Commissioner who oversees the pharma sector has called for greater co-operation on health technology assessment. John Dalli, the …

Germany raises health premiums to tackle budget deficit

July 9, 2010 Sales and Marketing Germany, economic climate, insurance

Chancellor Angela Merkel’s coalition government has agreed to raise health insurance premiums by over half a percent in a further …

Novel anticoagulants set to lead atrial fibrillation market

July 9, 2010 Sales and Marketing Brinavess, Multaq, Pradaxa, Xarelto, apixaban, atrial fibrilation

Novel anticoagulants set to capture the atrial fibrillation market by 2019, according to a new report. Analysts Decision Resources say …

Pharming forges production deal with Sanofi Chimie

July 8, 2010 Manufacturing and Production, Sales and Marketing HAE, Pharming, Ruconest, Sanofi Chimie

Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …

NICE poised to reject Novartis’ Afinitor

July 8, 2010 Sales and Marketing Afinitor, NICE, Novartis

Novartis’ kidney cancer drug Afinitor does not offer enough benefit to patients to justify its cost, according to draft guidance …
GSK alli iPhone app

Digital Pharma: Big pharma’s iPhone apps (part three)

July 7, 2010 Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

In the first two parts of Big Pharma’s iPhone Apps I looked at apps produced by 11 of the largest …

Roche submits new version of Herceptin for US approval

July 7, 2010 Research and Development, Sales and Marketing Herceptin, Roche, breast cancer

Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …

Italy plans cancer drug price cut

July 7, 2010 Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing

Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …

4Sight launches conference division

July 7, 2010 Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing

UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …

European scrutiny of pharma patent deals to continue

July 6, 2010 Sales and Marketing European Commission, competition, patents

Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …
Herceptin packs

NICE set to block Herceptin for gastric cancer

July 6, 2010 Sales and Marketing Herceptin, NICE, Roche, gastric cancer

NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …
Roche BioOncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part two)

July 5, 2010 Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

Part one of Big Pharma’s iPhone Apps covered apps produced by Pfizer, Merck & Co, GlaxoSmithKline, Sanofi-Aventis and Novartis and …
Margot James

Margot James: Tories to ‘nudge’ change in NHS

July 5, 2010 Medical Communications, Sales and Marketing NHS, government, pm society

Speaking to the industry for the first time since being elected as Conservative MP for Stourbridge at the recent General …

Lilly set to acquire Alnara Pharmaceuticals

July 5, 2010 Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly

Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …
Duncan-Learmouth

Duncan Learmouth to lead new GSK unit

July 5, 2010 Sales and Marketing GlaxoSmithKline, appointment, em, market access, sales and marketing

GlaxoSmithKline has created a new business group dedicated to improving access to medicines in the world’s least developed countries. GSK’s …
The Gateway to Local Adoption Series

Latest content